Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Fluticasone/Salmeterol Rotahaler vs Diskus in Asthma
NCT02218762Phase 1Withdrawn
- Sponsor
- GSK
- Start
- Oct 2014
- Primary completion
- Jun 2015
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, randomised, double-blind trial of fluticasone propionate and salmeterol in asthma (2 arms), sponsored by GSK. Primary endpoints: Fluticasone propionate Area Under the Curve over dosing interval and Salmeterol Maximum Observed Concentration. Planned start Oct 2014; status: withdrawn.
02
Drugs
fluticasone propionatesalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02218762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02218762.